Your browser doesn't support javascript.
loading
VHL inactivation without hypoxia is sufficient to achieve genome hypermethylation.
Artemov, Artem V; Zhigalova, Nadezhda; Zhenilo, Svetlana; Mazur, Alexander M; Prokhortchouk, Egor B.
Afiliación
  • Artemov AV; Institute of Bioengineering, Research Center of Biotechnology RAS, Moscow, Russia. artem.v.artemov@gmail.com.
  • Zhigalova N; Institute of Bioengineering, Research Center of Biotechnology RAS, Moscow, Russia.
  • Zhenilo S; Institute of Bioengineering, Research Center of Biotechnology RAS, Moscow, Russia.
  • Mazur AM; Institute of Bioengineering, Research Center of Biotechnology RAS, Moscow, Russia.
  • Prokhortchouk EB; Institute of Bioengineering, Research Center of Biotechnology RAS, Moscow, Russia. prokhortchouk@gmail.com.
Sci Rep ; 8(1): 10667, 2018 Jul 13.
Article en En | MEDLINE | ID: mdl-30006568
ABSTRACT
VHL inactivation is a key oncogenic event for renal carcinomas. In normoxia, VHL suppresses HIF1a-mediated transcriptional response, which is characteristic to hypoxia. It has previously been shown that hypoxic conditions inhibit TET-dependent hydroxymethylation of cytosines and cause DNA hypermethylation at gene promoters. In this work, we performed VHL inactivation by CRISPR/Cas9 and studied its effects on gene expression and DNA methylation. We showed that even without hypoxia, VHL inactivation leads to hypermethylation of the genome. Hypermethylated cytosines were evenly distributed throughout the genome with a slight preference for AP-1 (JUN and FOS) binding sites. Hypermethylated cytosines tended to be enriched within the binding sites of transcription factors that showed increased gene expression after VHL inactivation. We also observed promoter hypermethylation associated with decreased gene expression for several regulators of transcription and DNA methylation including SALL3.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Regulación Neoplásica de la Expresión Génica / Metilación de ADN / Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau / Neoplasias Renales Límite: Humans Idioma: En Revista: Sci Rep Año: 2018 Tipo del documento: Article País de afiliación: Rusia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Regulación Neoplásica de la Expresión Génica / Metilación de ADN / Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau / Neoplasias Renales Límite: Humans Idioma: En Revista: Sci Rep Año: 2018 Tipo del documento: Article País de afiliación: Rusia